Filing Details

Accession Number:
0001127602-13-018669
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-29 17:16:42
Reporting Period:
2013-05-28
Filing Date:
2013-05-29
Accepted Time:
2013-05-29 17:16:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376247 Richard Mulligan Biogen Idec Inc.
133 Boston Post Road
Weston MA 02493
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-28 35,000 $53.43 37,020 No 4 M Direct
Common Stock Disposition 2013-05-28 900 $238.11 36,120 No 4 S Direct
Common Stock Disposition 2013-05-28 8,497 $239.71 27,623 No 4 S Direct
Common Stock Disposition 2013-05-28 10,903 $240.45 16,720 No 4 S Direct
Common Stock Disposition 2013-05-28 10,006 $241.70 6,714 No 4 S Direct
Common Stock Disposition 2013-05-28 4,694 $242.27 2,020 No 4 S Direct
Common Stock Acquisiton 2013-05-28 2,975 $53.43 4,995 No 4 M Direct
Common Stock Disposition 2013-05-28 300 $237.51 4,695 No 4 S Direct
Common Stock Disposition 2013-05-28 1,975 $239.30 2,720 No 4 S Direct
Common Stock Disposition 2013-05-28 700 $239.74 2,020 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-28 35,000 $0.00 35,000 $53.43
Common Stock Stock Option (Right to Buy) Disposition 2013-05-28 2,975 $0.00 2,975 $53.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-06-02 No 4 M Direct
3,000 2010-06-03 2019-06-02 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
  3. This represents the weighted average price for shares sold at a range between $237.62(low) and $238.37(high).
  4. This represents the weighted average price for shares sold at a range between $239.09 (low) and $240.08 (high).
  5. This represents the weighted average price for shares sold at a range between $240.09(low) and $241.07(high).
  6. This represents the weighted average price for shares sold at a range between $241.11(low) and $242.10(high).
  7. This represents the weighted average price for shares sold at a range between $242.11 (low) and $242.52 (high).
  8. This represents the weighted average price for shares sold at a range between $237.38 (low) and $237.76(high).
  9. This represents the weighted average price for shares sold at a range between $238.65 (low) and $239.61 (high).
  10. This represents the weighted average price for shares sold at a range between $239.71 (low) and $239.78 (high).
  11. The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 06/03/2009.
  12. Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).